Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CONMED Corp
Report date March 01, 2018 · Filed March 05, 2018
Section 16 reporting ended · disclosed 2018-03-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2018-03-02 transaction · row 9
9 source rows · reconciled sequenceRow 1 · 2018-03-01 · Exercise / conversion · Acquired 600 · Balance 600 Row 2 · 2018-03-01 · Tax withholding · Disposed 252 · Balance 348 Row 3 · 2018-03-01 · Exercise / conversion · Acquired 650 · Balance 998 Row 4 · 2018-03-01 · Tax withholding · Disposed 273 · Balance 725 Row 5 · 2018-03-01 · Exercise / conversion · Acquired 10,020 · Balance 10,745 Row 6 · 2018-03-01 · Sale · Disposed 10,020 · Balance 725 F1: Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Row 7 · 2018-03-01 · Exercise / conversion · Acquired 9,600 · Balance 10,325 Row 8 · 2018-03-01 · Sale · Disposed 9,600 · Balance 725 F1: Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Row 9 · 2018-03-02 · Sale · Disposed 725 · Balance 0 |
| Rsus (restricted Stock Units)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2025-02-27 | Direct | 600 |
Reported balance
After 2018-03-01 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2018-03-01 · Exercise / conversion · Disposed 600 · Balance 600 F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. |
| Rsus (restricted Stock Units)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2026-03-01 | Direct | 1,300 |
Reported balance
After 2018-03-01 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2018-03-01 · Exercise / conversion · Disposed 650 · Balance 1,300 F3: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. |
| Options To Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $39.87 · Expires 2026-03-01 | Direct | 30,060 |
Reported balance
After 2018-03-01 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2018-03-01 · Exercise / conversion · Disposed 10,020 · Balance 30,060 F4: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period |
| Options To Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $41.93 · Expires 2027-03-01 | Direct | 38,400 |
Reported balance
After 2018-03-01 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2018-03-01 · Exercise / conversion · Disposed 9,600 · Balance 38,400 F4: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period |
Filing footnotes · ownership attribution and instrument terms
F1: Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.
F3: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.
F4: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2017 Filed Jun 2, 2017 16:13 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-020202 · form4.xml · nonDerivative · entry 5 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,413 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 16:13 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 370 | $51.90 | $19,203.00 |
DisclosureSEC source: 0001127602-17-020202 · form4.xml · nonDerivative · entry 4 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,413 Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 16:13 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-020202 · form4.xml · nonDerivative · entry 3 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,783 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 16:13 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 296 | $51.90 | $15,362.40 |
DisclosureSEC source: 0001127602-17-020202 · form4.xml · nonDerivative · entry 2 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,783 Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 16:13 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 800 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-020202 · form4.xml · nonDerivative · entry 1 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,079 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 16:17 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 48,000 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-17-009947 · form4.xml · derivative · entry 7 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,000 Underlying: Common Stock · 48,000 shares Expires 2027-03-01 F3 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 16:17 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 650 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009947 · form4.xml · derivative · entry 6 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,950 Underlying: Common Stock · 650 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 16:17 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009947 · form4.xml · derivative · entry 5 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,200 Underlying: Common Stock · 600 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 16:17 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 275 | $41.93 | $11,530.75 |
DisclosureSEC source: 0001127602-17-009947 · form4.xml · nonDerivative · entry 4 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,279 Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 16:17 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 650 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009947 · form4.xml · nonDerivative · entry 3 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,554 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 16:17 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 254 | $41.93 | $10,650.22 |
DisclosureSEC source: 0001127602-17-009947 · form4.xml · nonDerivative · entry 2 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,904 Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 16:17 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009947 · form4.xml · nonDerivative · entry 1 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,158 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.